
Alpha Profiles · Company Profile
ALNYLAM PHARMACEUTICALS, INC.
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: ALNY
- Verification
- Partially verified
- Last reviewed
- 2026-09-13T04:45:14.103186+00:00
Overview
Alpha's canonical identity and public leadership record for ALNYLAM PHARMACEUTICALS, INC..
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
9 public recordsChief Legal Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 86%
- Evidence
- Alnylam Pharmaceuticals key executivesApr 24, 2026
Chief Corporate Communications Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 86%
- Evidence
- Alnylam Pharmaceuticals key executivesApr 24, 2026
Chief Financial Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- ALNY executive roster sourceMay 3, 2026
Executive Vice President, Chief Scientific Officer and Head of Early Research & Early Development
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 86%
- Evidence
- Alnylam Pharmaceuticals key executivesApr 24, 2026
Chief Ethics & Compliance Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 86%
- Evidence
- Alnylam Pharmaceuticals key executivesApr 24, 2026
EVice President of Development & Medical Affairs and Chief Research & Dev. Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 86%
- Evidence
- Alnylam Pharmaceuticals key executivesApr 24, 2026
Chief Technical Operations & Quality Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 86%
- Evidence
- Alnylam Pharmaceuticals key executivesApr 24, 2026
Executive VP & Chief Commercial Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 86%
- Evidence
- Alnylam Pharmaceuticals key executivesApr 24, 2026
President and Chief Executive Officer
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- ALNY executive roster sourceMay 3, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
10 public records- State
- confirmed
- Effective
- From Jan 1, 2014
- Confidence
- 85%
- Evidence
- Alnylam Pharmaceuticals DEF 14A 2026-04-06Apr 6, 2026
- State
- confirmed
- Effective
- From Jan 1, 2018
- Confidence
- 85%
- Evidence
- Alnylam Pharmaceuticals DEF 14A 2026-04-06Apr 6, 2026
- State
- confirmed
- Effective
- From Jan 1, 2015
- Confidence
- 85%
- Evidence
- Alnylam Pharmaceuticals DEF 14A 2026-04-06Apr 6, 2026
- State
- confirmed
- Effective
- From Jan 1, 2012
- Confidence
- 85%
- Evidence
- Alnylam Pharmaceuticals DEF 14A 2026-04-06Apr 6, 2026
- State
- confirmed
- Effective
- From Jan 1, 2022
- Confidence
- 85%
- Evidence
- Alnylam Pharmaceuticals DEF 14A 2026-04-06Apr 6, 2026
- State
- confirmed
- Effective
- From Jan 1, 2019
- Confidence
- 85%
- Evidence
- Alnylam Pharmaceuticals DEF 14A 2026-04-06Apr 6, 2026
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- Alnylam Pharmaceuticals DEF 14A 2026-04-06Apr 6, 2026
- State
- confirmed
- Effective
- From Jan 1, 2023
- Confidence
- 85%
- Evidence
- Alnylam Pharmaceuticals DEF 14A 2026-04-06Apr 6, 2026
- State
- confirmed
- Effective
- From Jan 1, 2026
- Confidence
- 85%
- Evidence
- Alnylam Pharmaceuticals DEF 14A 2026-04-06Apr 6, 2026
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Alnylam Pharmaceuticals DEF 14A 2026-04-06Apr 6, 2026
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-09-13T04:45:14.103186+00:00
